ROBODOC® Clinical Trials: Long-Term Follow-Up
NCT01831219 is an observational study sponsored by Curexo Technology Corporation. As of 21 Nov 2026, it is completed. It studies Osteoarthritis. The registry lists an enrollment of 118 participants at 1 site in 1 country. The registry lists a start date of 30 Apr 2013 and a primary completion date of 31 Jan 2016.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01831219 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Curexo Technology Corporation |
| Enrollment | 118 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Osteoarthritis |
| Start | 30 Apr 2013 |
| Primary completion | 31 Jan 2016 |
| Study completion | 31 Jan 2016 |
| Last update posted | 11 Jan 2017 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- William L Bargar, MD
Department of Orthopaedics, University of California at Davis
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sutter Institute for Medical Research
Sacramento
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01831219
Each answer restates registry values shown on this page.
What is NCT01831219?
NCT01831219 is an observational study sponsored by Curexo Technology Corporation. It studies Osteoarthritis.
Who leads NCT01831219?
The registry names William L Bargar, MD (principal investigator, Department of Orthopaedics, University of California at Davis) as the overall official.
Where does NCT01831219 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT01831219 end?
The registry lists a primary completion date of 31 Jan 2016 and a study completion date of 31 Jan 2016. The sponsor last updated the record on 11 Jan 2017.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.